| A characterization of bridging therapies leading up to commercial CAR T-cell therapy SD Nasta, ME Hughes, EC Namoglu, DJ Landsburg, EA Chong, SK Barta, ... Blood 134, 4108, 2019 | 20 | 2019 |
| Hospitalization patterns with commercial CAR T-cell therapy: a single institution experience SD Nasta, EC Namoglu, ME Hughes, EA Chong, J Svoboda, HJ Ballard, ... Blood 134, 3240, 2019 | 18 | 2019 |
| Treatment of patients with relapsed/refractory non-hodgkin lymphoma with venetoclax: a single-center evaluation of off-label use ME Hughes, DJ Landsburg, DJ Rubin, SJ Schuster, J Svoboda, ... Clinical Lymphoma Myeloma and Leukemia 19 (12), 791-798, 2019 | 14 | 2019 |
| Outcomes of tisagenlecleucel in lymphoma patients with predominant management in an ambulatory setting SD Nasta, ME Hughes, EC Namoglu, A Garfall, H DiFilippo, HJ Ballard, ... Clinical Lymphoma Myeloma and Leukemia 22 (8), e730-e737, 2022 | 12 | 2022 |
| Use of bendamustine for lymphodepletion before tisagenlecleucel (anti-CD19 CAR T cells) for aggressive B-cell lymphomas J Svoboda, HJ Ballard, EA Chong, MI LaRose, SM Bair, EC Namoglu, ... Blood 134, 1606, 2019 | 12 | 2019 |
| 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma A Ruff, HJ Ballard, AR Pantel, EC Namoglu, ME Hughes, SD Nasta, ... Molecular imaging and biology 23, 818-826, 2021 | 11 | 2021 |
| The 100 most mentioned glaucoma articles online with highest altmetric attention scores JL Chien, J Sabharwal, EC Namoglu, MP Ghassibi, M Yuan, C Gandy, ... Journal of glaucoma 31 (1), 8-14, 2022 | 10 | 2022 |
| Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease) EC Namoglu, ME Hughes, JP Plastaras, DJ Landsburg, A Maity, ... Leukemia & Lymphoma 61 (4), 905-911, 2020 | 9 | 2020 |
| A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma MJ Cortese, W Wei, S Cerdeña, MP Watkins, M Olson, G Jodon, J Kaiser, ... Leukemia & Lymphoma 64 (1), 107-118, 2023 | 4 | 2023 |
| Willingness to travel for cellular therapy: the influence of follow-up care location, oncologist continuity, and race ZAK Frosch, EC Namoglu, N Mitra, DJ Landsburg, SD Nasta, ... JCO Oncology Practice 18 (1), e193-e203, 2022 | 4 | 2022 |
| Restriction enzyme based enriched L1Hs sequencing (REBELseq): a scalable technique for detection of Ta subfamily L1Hs in the human genome BC Reiner, GA Doyle, AE Weller, RN Levinson, E Namoglu, A Pigeon, ... G3: Genes, Genomes, Genetics 10 (5), 1647-1655, 2020 | 4 | 2020 |
| Inherited L1 retrotransposon insertions associated with risk for schizophrenia and bipolar disorder BC Reiner, GA Doyle, AE Weller, RN Levinson, AM Rao, E Davila Perea, ... Schizophrenia Bulletin Open 2 (1), sgab031, 2021 | 3 | 2021 |
| Targeted immunotherapies to consider for B Cell non-hodgkin lymphoma EC Namoglu, ME Hughes, SD Nasta Expert Review of Precision Medicine and Drug Development 6 (5), 317-332, 2021 | | 2021 |
| Willingness to travel for CAR-T: A choice-based conjoint analysis. ZAK Frosch, EC Namoglu, N Mitra, DJ Landsburg, S Nasta, J Shea, ... Journal of Clinical Oncology 39 (15_suppl), e18503-e18503, 2021 | | 2021 |
| Clinical Outcomes of Non-Hodgkin Lymphoma Patients on Acalabrutinib Including Off-Label Utilization EC Namoglu, ME Hughes, DJ Landsburg, SJ Schuster, J Svoboda, ... Blood 134, 5261, 2019 | | 2019 |
| Clinical Outcomes of Obinutuzumab Therapy across Non-Hodgkin Lymphoma Subtypes ME Hughes, EC Namoglu, C Suen, SJ Schuster, J Svoboda, ... Blood 134, 5247, 2019 | | 2019 |
| Evaluation of American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS) Surgeons’ Social Media Presence and Online Reviews KH Chang, LJ Wang, R Salehi, EC Namoglu, A Gu, PL Kuo, MP Ghassibi, ... Investigative Ophthalmology & Visual Science 60 (9), 5488-5488, 2019 | | 2019 |
| Evaluation of Ophthalmology Residency Program Websites: Analysis of Contents of 111 Programs in the United States P Wu, EC Namoglu, JL Chien, A Gu, MP Ghassibi, D Belyea, G Sun Investigative Ophthalmology & Visual Science 60 (9), 5484-5484, 2019 | | 2019 |
| Restriction Enzyme Based Enriched L1Hs sequencing (REBELseq) BC Reiner, GA Doyle, AE Weller, RN Levinson, E Namoglu, A Pigeon, ... bioRxiv, 710095, 2019 | | 2019 |
| REAL WORLD OUTCOMES OF OBINUTUZUMAB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA ME Hughes, C Suen, E Namoglu, SJ Schuster, J Svoboda, DJ Landsburg, ... Hematological Oncology 37, 378-379, 2019 | | 2019 |
